INTERNATIONAL PATENT: PHIO PHARMACEUTICALS CORP. FILES APPLICATION FOR "ENHANCED COMBINATION IMMUNE CHECKPOINT INHIBITION THERAPY UTILIZING RNAI"

GENEVA, June 12 -- PHIO PHARMACEUTICALS CORP. (11 Apex Dr., Ste 300aPmb 2006Marlborough, MA 01752) filed a patent application (PCT/US2024/057805) for "ENHANCED COMBINATION IMMUNE CHECKPOINT INHIBITION THERAPY UTILIZING RNAI" on Nov 27, 2024. With publication no. WO/2025/117786, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MAXWELL, Melissa (148 Walnut St.Clinton, MA 01510), CARDIA, James (11 Bacon StreetFranklin, MA 02038), FRICKER, Simon (13 Glenwood LaneNorth Grafton, MA 01536), CUIFFO, Benjamin (38 Walnut StreetNatic...